Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric London, MD
New York State Institute for Basic Research (IBR)
Principal Investigator - Jeremy Veenstra-VanderWeele, MD
New York State Psychiatric Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- New York State Institute for Basic Research (ibr)
Staten Island, New York, United States
Eric London, MDJiyeon Helen Yoo, PhDRecruiting - Center for Autism and the Developing Brain
White Plains, New York, United States
Jeremy Veenstra-VanderWeele, MDKaren Tang, PhDPankhuree Vandana, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jan 2026
- Primary completion
- 30 Nov 2028
- Completion
- 31 Dec 2028
- Last update posted
- 30 Mar 2026
- Registered enrollment
- 60
- Registry id
- NCT07091279
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.